Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|March 14, 2007
[A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib]Hisao Imai, Yoshio Tomizawa, Shinichi Ishihara, et al.
American Journal of Clinical Oncology|October 11, 2008
Impact of preexisting pulmonary fibrosis detected on chest radiograph and CT on the development of gefitinib-related interstitial lung diseaseYoichi Naito, Satoshi Tsuchiya, Shinichi Ishihara, et al.
Chemotherapy|April 6, 2017
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line ChemotherapyMie Kotake, Yosuke Miura, Hisao Imai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 7, 2002
Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibilityNoriaki Sunaga, Takashi Kohno, Noriko Yanagitani, et al.
Anti-Cancer Drugs|March 5, 2005
Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancerKyoichi Kaira, Atsushi Takise, Koichi Minato, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2009
Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapyYoshio Tomizawa, Yuka Fujita, Atsuhisa Tamura, et al.
Molecular and Clinical Oncology|July 24, 2014
Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor geneReiko Yoshino, Hisao Imai, Keita Mori, et al.
International Journal of Hematology|November 8, 2014
Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphomaIkue Okamura, Hisao Imai, Keita Mori, et al.
American Journal of Clinical Oncology|February 7, 2007
A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancerKyoichi Kaira, Satoshi Tsuchiya, Noriaki Sunaga, et al.
Cancer Medicine|September 19, 2019
Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II studyJun-Ichi Saitoh, Katsuyuki Shirai, Tatsuji Mizukami, et al.
Pageof 7